Oviva has secured $80 million in Series C funding, co-led by Sofina and Temasek, to expand its digital health coaching services across Europe.

Information on the Target

Oviva is a digital health scaleup founded in 2014 that specializes in providing dietary and lifestyle coaching for individuals facing diet-related health challenges. The company aims to empower its users by helping them change their eating habits, which contributes to better long-term health and overall wellbeing. Oviva utilizes a combination of personalized coaching and an intuitive mobile application to facilitate this transformation, employing only certified dietitians to ensure compliance with health system regulations.

The innovative approach taken by Oviva not only benefits individuals but also integrates with health insurance systems, making its services accessible and financially feasible for users. This allows Oviva to reach a broader audience while maintaining a focus on quality and effectiveness in dietary management.

Industry Overview in the Target’s Specific Country

The digital health market in Europe is experiencing significant growth, fueled by the increasing prevalence of lifestyle-related diseases and rising healthcare costs. The shift towards preventive health measures has encouraged individuals to seek out

View Source

Similar Deals

AstraZeneca Harbour BioMed

2025

Other Bio Therapeutic Drugs Other
Lotus Pharmaceutical Co., Ltd. LENZ Therapeutics, Inc.

2025

Other Proprietary & Advanced Pharmaceuticals Other
Teleflex BIOTRONIK Vascular Intervention

2025

Other Medical Devices & Implants Other
Mérieux NutriSciences food testing business of Bureau Veritas

2024

Other Advanced Medical Equipment & Technology (NEC) Other

Sofina, Temasek, AlbionVC, Earlybird, Eight Roads Ventures, F-Prime Capital, MTIP, Various angel investors

invested in

Oviva

in 2023

in a Other deal

Disclosed details

Transaction Size: $80M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert